Search for: "Astrazeneca" Results 41 - 60 of 1,247
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2014, 4:49 am by Vickie Nijjar
Some people, including the AstraZeneca shareholders, may be wondering why the Board effectively prevented the shareholders from taking Pfizer’s offer that would produce £55 a share. [read post]
22 May 2014, 4:49 am by Vickie Nijjar
Some people, including the AstraZeneca shareholders, may be wondering why the Board effectively prevented the shareholders from taking Pfizer’s offer that would produce £55 a share. [read post]
29 Apr 2010, 7:43 am by fraudfighters
  The lawsuit also alleged that AstraZeneca violate the federal Anti-Kickback Statute by offering and paying illegal remuneration to the doctors it recruited to serve as authors of articles written by AstraZeneca and its agents about the off-label uses of Seroquel. [read post]
28 Dec 2016, 7:23 am by Robert Kraft
” Judge Moss “ruled that AstraZeneca was not likely to win a lawsuit claiming it should get seven more years of exclusive rights to the drug thanks to its recent approval to treat a rare pediatric illness. [read post]
12 Oct 2010, 12:00 am by JA Hodnicki
Daniel Sokol David Hull (Covington) explains The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. [read post]
27 Apr 2010, 12:57 pm by Andy Jones
AstraZeneca has agreed to pay $520 million to settle charges that it illegally marketed the anti-psychotic drug Seroquel, the U.S. [read post]
12 Oct 2010, 12:00 am by JA Hodnicki
Daniel Sokol David Hull (Covington) explains The AstraZeneca Judgment: Implications for IP and Regulatory Strategies. [read post]
23 Feb 2021, 7:39 am by Brian Leiter
This is welcome news: Research led by Public Health Scotland found at four weeks after the first dose, hospital admissions were reduced by 85% and 94% for the Pfizer and AstraZeneca jabs respectively. [read post]
31 Jul 2009, 6:15 am
The Wall Street Journal reports, "AstraZeneca said it has set aside provisions of $430 million in relation to various federal and state investigations and civil lawsuits, relating to the company's marketing and pricing practices. [read post]
12 Sep 2020, 8:59 am by Tom Smith
A large, United Kingdom-based Phase 2/3 study testing a Covid-19 vaccine being developed by AstraZeneca has been restarted, according to a statement from the company. [read post]
27 Apr 2010, 3:36 pm by Phillips & Cohen
Dept. of Justice announced that pharmaceutical company AstraZeneca will pay $520 million to settle allegations of off-label marketing.Charges that the company illegally marketed the anti-psychotic drug Seroquel were originally raised in a lawsuit brought under the qui tam provisions of the False Claims Act.The civil settlement resolves allegations that by marketing Seroquel for uses that had not been approved by the FDA, the company caused false claims for payment to be submitted to federal… [read post]
23 Apr 2007, 9:23 pm
Singer -- AstraZeneca PLC announced on Monday that it plans to acquire MedImmune Inc. in a deal estimated to be worth about $15 billion. [read post]
After more than four years of litigation, AstraZeneca has agreed to pay $2.5 million to settle State of Idaho v. [read post]
12 Jun 2008, 9:35 pm
To say the least, AstraZeneca expressed disappointment with the ruling of noninfringement regarding it’s U.S. [read post]
14 Oct 2010, 12:00 am by JA Hodnicki
Daniel Sokol Kristina Nordlander & Patrick Harrison (Sidley Austin) predict the General Court’s AstraZeneca Judgment Set to Embolden Commission. [read post]
22 Mar 2021, 1:51 pm by Associated Press
WASHINGTON — AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S. [read post]
20 Jul 2010, 12:58 pm by mcarzima@imediainc.com
In April of 2010, AstraZeneca LP and AstraZeneca Pharmaceuticals agreed to pay $520 million to resolve claims that the company marketed the drug Seroquel for off-label purposes and provided kick-backs to doctors who promoted its use. [read post]
1 Jun 2022, 12:11 pm by jeffreynewmanadmin
The US Securities and Exchange Commission has filed a suit against former AstraZeneca executive over alleged insider trading in connection with its 2019 deal to acquire rights to Daiichi Sankyo’s breast cancer therapy Enhertu. [read post]